These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28584146)

  • 21. Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens.
    Pamer EG
    Science; 2016 Apr; 352(6285):535-8. PubMed ID: 27126035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
    Pultz MJ; Donskey CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3044-5. PubMed ID: 17562802
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibiotic-Induced Alterations of the Gut Microbiota Alter Secondary Bile Acid Production and Allow for Clostridium difficile Spore Germination and Outgrowth in the Large Intestine.
    Theriot CM; Bowman AA; Young VB
    mSphere; 2016; 1(1):. PubMed ID: 27239562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colonization resistance of the human intestinal microflora: testing the hypothesis in normal volunteers.
    Gorbach SL; Barza M; Giuliano M; Jacobus NV
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):98-102. PubMed ID: 3132394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiome-related metabolic changes in plasma of antibiotic-treated rats.
    Behr C; Kamp H; Fabian E; Krennrich G; Mellert W; Peter E; Strauss V; Walk T; Rietjens IMCM; van Ravenzwaay B
    Arch Toxicol; 2017 Oct; 91(10):3439-3454. PubMed ID: 28337503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract.
    Gutierrez D; Weinstock A; Antharam VC; Gu H; Jasbi P; Shi X; Dirks B; Krajmalnik-Brown R; Maldonado J; Guinan J; Thangamani S
    FEMS Microbiol Ecol; 2020 Jan; 96(1):. PubMed ID: 31769789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Replacement of third-generation cephalosporins by piperacillin-tazobactam decreases colonization of extended-spectrum beta-lactamases-producing intestinal Escherichia coli].
    Zhao ZM; Chu YZ; Wan JH; Bai YL; Zhang JP; Li JB; Wang X; Wang Q; Li LY; Chen BY
    Zhonghua Nei Ke Za Zhi; 2007 Sep; 46(9):714-7. PubMed ID: 18028795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
    Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-invasive Qualitative Urinary Metabolomic Profiling Discriminates Gut Microbiota Derived Metabolites in the Moderate and Chronic Alcoholic Cohorts.
    Dabur R; Shirolkar A; Mishra V; Yadav BS
    Curr Pharm Biotechnol; 2017; 18(14):1175-1189. PubMed ID: 29521221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI.
    Taneja N; Rao P; Arora J; Dogra A
    Indian J Med Res; 2008 Jan; 127(1):85-8. PubMed ID: 18316858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae.
    Harada Y; Morinaga Y; Kaku N; Nakamura S; Uno N; Hasegawa H; Izumikawa K; Kohno S; Yanagihara K
    Clin Microbiol Infect; 2014 Nov; 20(11):O831-9. PubMed ID: 24813594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonylphenol Toxicity Evaluation and Discovery of Biomarkers in Rat Urine by a Metabolomics Strategy through HPLC-QTOF-MS.
    Zhang YX; Yang X; Zou P; Du PF; Wang J; Jin F; Jin MJ; She YX
    Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
    Varotto F; Maria GD; Azzaro R; Bellissima P; Amato R; Fogliani V; Muscianisi G; Vitale S; Girbino G; Andò F; Laganà P; Delia S; Jacoviello C; Maierna G; Pezza A; Covelli I; Magrì M; Napoletano G; Rossi A; Marone P; Sanguinetti C; Pela R; Tedeschi D; Viola B; Cicciarella S; Messina G; Rizza S; Fraschini F
    J Chemother; 2001 Aug; 13(4):413-23. PubMed ID: 11589485
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Stainton SM; Monogue ML; Nicolau DP
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28607019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice.
    Pultz NJ; Stiefel U; Ghannoum M; Helfand MS; Donskey CJ
    Antimicrob Agents Chemother; 2005 Jan; 49(1):438-40. PubMed ID: 15616330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry.
    Barco S; Bandettini R; Maffia A; Tripodi G; Castagnola E; Cangemi G
    J Chemother; 2015; 27(6):343-7. PubMed ID: 25178412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK; Mendes RE; Silbert S; Bolsoni AP; Sader HS
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
    Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
    Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/tazobactam.
    dos Santos KV; Diniz CG; Veloso Lde C; de Andrade HM; Giusta Mda S; Pires Sda F; Santos AV; Apolônio AC; de Carvalho MA; Farias Lde M
    Res Microbiol; 2010 May; 161(4):268-75. PubMed ID: 20381611
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.